Raffles Medical Group Ltd (SGX:BSL)
Singapore · Delayed Price · Currency is SGD | Market Cap | 1.84B +19.3% |
| Revenue (ttm) | 765.17M +8.8% |
| Net Income | 63.71M +4.5% |
| EPS | 0.03 +6.0% |
| Shares Out | 1.84B |
| PE Ratio | 29.14 |
| Forward PE | 26.78 |
| Dividend | 0.03 (2.51%) |
| Ex-Dividend Date | May 13, 2025 |
| Volume | 2,541,200 |
| Average Volume | 1,172,965 |
| Open | 0.995 |
| Previous Close | 0.995 |
| Day's Range | 0.985 - 1.000 |
| 52-Week Range | 0.820 - 1.090 |
| Beta | 0.18 |
| RSI | 49.31 |
| Earnings Date | Feb 23, 2026 |
About Raffles Medical Group
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. Its Raffles Hospital, a tertiary care hospital that offers 24-hour acute and critical care, family medicine services, health screening, and a range of multi-disciplinary specialist clinics; appointed wards, day surgery, angiography suites, delivery suites, operating theatres, i... [Read more]
Financial Performance
In 2024, Raffles Medical Group's revenue was 752.41 million, an increase of 6.27% compared to the previous year's 708.04 million. Earnings were 62.24 million, a decrease of -30.96%.
Financial StatementsNews
Raffles Medical Group: China business still grew in 2024
Loo Choon Yong, Executive Chairman of Raffles Medical Group, talks about business in China and the country's efforts to liberalize its healthcare market.